Cancer Genomics

New research published today showcases the importance of whole genome sequencing for our cancer patients

Everyday patients benefit from genomic testing. New research published today shows how important genomics has become in the treatment of cancer. The findings, published today by Genomics England in Nature Medicine, show just how much doctors and scientists have learnt over the past 5 years about how genetics can influence cancer and inform how we …

New research published today showcases the importance of whole genome sequencing for our cancer patients Read More »

Genetic Counsellor, Andrea Foreman shares her top tips for anyone working in cancer who may come across patients with Lynch Syndrome.

Seeing the impact that the Lynch Syndrome screening programme has on people has lit a fire in me!

Andrea is a genetic counsellor and is passionate about supporting people through genetic testing for cancer. “When I first qualified 20 years ago, there was only a handful of genetic tests available for cancer. Now, the world of genomics has changed so much that we are able to offer multiple genetic tests for a whole …

Seeing the impact that the Lynch Syndrome screening programme has on people has lit a fire in me! Read More »

SE Genomics Autumn Festival

We are keen to promote our second upcoming virtual event – SE Genomics Autumn Festival. Speakers will provide an overview of how the latest developments in genomics are impacting cancer care and share their expertise on different cancer genomics pathways and the tests available. Register now via Eventbrite and please share with your networks as …

SE Genomics Autumn Festival Read More »

National workshop: From diagnosis of cancer to diagnosis of Lynch syndrome

  Workshops focused around the roles and responsibilities of local cancer MDT members in the Lynch syndrome testing pathway.   Lynch syndrome (LS) is an inherited condition caused by pathogenic variants in DNA genes which result in an increased risk of colorectal, endometrial, and other cancers. Increases risk of developing bowel cancer to up to 80% …

National workshop: From diagnosis of cancer to diagnosis of Lynch syndrome Read More »

With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
 
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
 
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
 
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.